The Science and Innovation Behind Jubileye Health: A Breakthrough in Dry Eye & Glare Defense

How advanced research and clinically studied ingredients are redefining eye comfort and visual clarity.
Morningstar

New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)

PALO ALTO, Calif., Sept. 15, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing ...
Ophthalmology Times

PRIMAvera study: Central vision improvement with subretinal implant

The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors. In a clinical trial, 81% of patients showed significant visual acuity ...
Seeking Alpha

New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)

Meaningful vision gains are rapidly achieved as early as week 4 and more than half of patients in the top two dose levels improved 3-lines or more on the eye chart (≥15 letter gain) A single dose of ...